256 related articles for article (PubMed ID: 25421691)
1. Epigenetic therapy for colorectal cancer.
Vaish V; Khare T; Verma M; Khare S
Methods Mol Biol; 2015; 1238():771-82. PubMed ID: 25421691
[TBL] [Abstract][Full Text] [Related]
2. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Drug Therapy in the Treatment of Colorectal Cancer.
Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Seifi S; Parizadeh SMR; Moetamani-Ahmadi M; Hassanian SM; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Avan A
Curr Pharm Des; 2018; 24(23):2701-2709. PubMed ID: 30062956
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
[TBL] [Abstract][Full Text] [Related]
6. The role of epigenetic therapies in colorectal cancer.
Baretti M; Azad NS
Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
8. Small-molecular modulators of cancer-associated epigenetic mechanisms.
Itoh Y; Suzuki T; Miyata N
Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
10. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics of colorectal cancer.
Migheli F; Migliore L
Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
[TBL] [Abstract][Full Text] [Related]
12. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
[TBL] [Abstract][Full Text] [Related]
13. Histone Deacetylase Modifications by Probiotics in Colorectal Cancer.
Salek Farrokhi A; Mohammadlou M; Abdollahi M; Eslami M; Yousefi B
J Gastrointest Cancer; 2020 Sep; 51(3):754-764. PubMed ID: 31808058
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
15. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation in colorectal cancer: The susceptibility of microRNAs 145, 143 and 133b to DNA demethylation and histone deacetylase inhibitors.
Omar A; Govan D; Penny C
PLoS One; 2023; 18(8):e0289800. PubMed ID: 37561735
[TBL] [Abstract][Full Text] [Related]
18. In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.
Maes K; De Smedt E; Kassambara A; Hose D; Seckinger A; Van Valckenborgh E; Menu E; Klein B; Vanderkerken K; Moreaux J; De Bruyne E
Oncotarget; 2015 Feb; 6(5):3319-34. PubMed ID: 25669970
[TBL] [Abstract][Full Text] [Related]
19. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Regulation and Promising Therapies in Colorectal Cancer.
Kishore C
Curr Mol Pharmacol; 2021; 14(5):838-852. PubMed ID: 33573584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
